Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109 USD | -1.36% | -0.58% | -11.39% |
05-13 | US reclassification could drive fresh research funding into pot sector | RE |
05-07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.39% | 6.97B | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- (JAZZ) JAZZ PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $18.15 - $19.35